Bioequivalence Study of Zafirlukast Tablets 20 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition
NCT01283061
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Zafirlukast
Sponsor
Dr. Reddy's Laboratories Limited